NeuroPace (NPCE) Short Interest Ratio & Short Volume $17.62 -0.37 (-2.06%) As of 12:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NeuroPace Short Interest DataNeuroPace (NPCE) has a short interest of 393,700 shares, representing 1.70% of the float (the number of shares available for trading by the public). This marks a 13.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 144,064 shares to cover all short positions.Current Short Interest393,700 sharesPrevious Short Interest347,500 sharesChange Vs. Previous Month+13.29%Dollar Volume Sold Short$4.60 millionShort Interest Ratio1.7 Days to CoverLast Record DateApril 30, 2025Outstanding Shares32,799,000 sharesFloat Size23,130,000 sharesShort Percent of Float1.70%Today's Trading Volume99,006 sharesAverage Trading Volume144,064 sharesToday's Volume Vs. Average69% Short Selling NeuroPace? Sign up to receive the latest short interest report for NeuroPace and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNPCE Short Interest Over TimeNPCE Days to Cover Over TimeNPCE Percentage of Float Shorted Over Time NeuroPace Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025393,700 shares $4.60 million +13.3%1.7%1.7 $11.69 4/15/2025347,500 shares $3.59 million -22.7%1.5%1.5 $10.34 3/31/2025449,600 shares $5.53 million +45.8%2.0%1.9 $12.29 3/15/2025308,300 shares $3.30 million +25.5%1.3%1.4 $10.69 2/28/2025245,600 shares $3.18 million +7.7%1.1%1.3 $12.95 2/15/2025228,000 shares $2.81 million +3.9%1.1%1.4 $12.31 1/31/2025219,400 shares $3.02 million -17.8%1.6%1.8 $13.76 1/15/2025267,000 shares $3.20 million +1.4%1.9%2.6 $12.00 12/31/2024263,300 shares $2.95 million +4.7%1.9%3.2 $11.19 12/15/2024251,400 shares $2.77 million +0.8%1.8%3.1 $11.03 Get the Latest News and Ratings for NPCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024249,400 shares $2.64 million -14.1%1.8%3.3 $10.60 11/15/2024290,400 shares $2.61 million -33.7%2.1%4 $8.98 10/31/2024437,900 shares $2.82 million -14.0%3.3%6.3 $6.45 10/15/2024509,200 shares $3.29 million -4.5%3.5%9 $6.46 9/30/2024532,900 shares $3.71 million +5.2%3.7%8.8 $6.97 9/15/2024506,400 shares $3.76 million -2.2%3.5%5.6 $7.43 8/31/2024517,800 shares $4.10 million +6.0%3.7%5.4 $7.92 8/15/2024488,300 shares $3.46 million +2.1%3.4%4.6 $7.10 7/31/2024478,400 shares $3.70 million +8.8%3.4%4.2 $7.73 7/15/2024439,700 shares $3.39 million +223.8%3.1%3.6 $7.70 6/30/2024135,800 shares $1.03 million +56.6%1.0%1 $7.56 6/15/202486,700 shares $560,082.00 +16.9%0.6%0.8 $6.46 5/31/202474,200 shares $512,722.00 -40.9%0.5%0.7 $6.91 5/15/2024125,500 shares $1.13 million +39.8%0.9%1.1 $9.03 4/30/202489,800 shares $1.17 million -7.5%0.7%0.8 $12.99 4/15/202497,100 shares $1.30 million +13.0%0.7%0.9 $13.40 3/31/202485,900 shares $1.13 million +178.0%0.7%0.9 $13.20 3/15/202430,900 shares $407,262.00 -38.6%0.3%0.3 $13.18 2/29/202450,300 shares $813,351.00 -19.8%0.4%0.6 $16.17 2/15/202462,700 shares $1.01 million -0.5%0.6%0.7 $16.08 1/31/202463,000 shares $921,060.00 +76.0%0.6%0.8 $14.62 1/15/202435,800 shares $410,626.00 -43.6%0.3%0.4 $11.47 12/31/202363,500 shares $654,685.00 -32.5%0.6%0.9 $10.31 12/15/202394,100 shares $852,546.00 -26.9%0.9%1.6 $9.06 11/30/2023128,800 shares $1.16 million -14.7%1.2%2.2 $8.99 11/15/2023151,000 shares $1.31 million -61.8%1.4%2.2 $8.70 10/31/2023395,600 shares $2.67 million +26.4%3.7%4.5 $6.75 10/15/2023313,100 shares $1.88 million +2.0%3.0%3.9 $6.01 9/30/2023307,100 shares $2.99 million -12.8%2.9%4.1 $9.73 9/15/2023352,200 shares $3.05 million -20.2%3.3%4.9 $8.66Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 8/31/2023441,100 shares $4.14 million -7.8%4.3%6.7 $9.39 8/15/2023478,400 shares $2.15 million +1.3%4.6%14.2 $4.50 7/31/2023472,400 shares $1.96 million +0.5%4.7%26.1 $4.15 7/15/2023470,000 shares $1.97 million -0.8%5.1%37 $4.19 6/30/2023474,000 shares $2.13 million +2.5%5.2%30.4 $4.49 6/15/2023462,500 shares $2.08 million -0.3%5.0%27.4 $4.50 5/31/2023464,000 shares $2.06 million -1.0%5.6%27.5 $4.45 5/15/2023468,800 shares $1.92 million +0.2%5.7%19.2 $4.10 4/30/2023467,700 shares $2.34 million -27.0%5.6%17.7 $5.00 4/15/2023640,800 shares $3.08 million -0.7%7.8%25.6 $4.80 3/31/2023645,600 shares $3.00 million +1.3%8.0%22.4 $4.64 3/15/2023637,400 shares $2.17 million +0.4%7.9%9.8 $3.40 2/28/2023635,000 shares $3.26 million +1.0%7.9%9.5 $5.13 2/15/2023628,500 shares $2.93 million -2.3%7.9%9 $4.66 1/31/2023643,000 shares $3.01 million +7.4%7.5%6.2 $4.68 1/15/2023598,500 shares $2.03 million +0.5%6.9%5.7 $3.40 12/30/2022595,300 shares $886,997.00 -0.2%6.9%5.8 $1.49 12/15/2022596,700 shares $948,753.00 -1.7%6.9%5.9 $1.59 11/30/2022606,700 shares $976,787.00 -3.0%7.1%8.9 $1.61 11/15/2022625,500 shares $1.22 million +2.0%7.0%9.4 $1.95 10/31/2022613,300 shares $1.84 million +0.3%7.0%25.1 $3.00 10/15/2022611,700 shares $1.93 million -1.0%7.0%23.3 $3.15 9/30/2022618,100 shares $2.32 million -0.6%20.6%23.1 $3.75 9/15/2022621,500 shares $2.52 million -1.1%20.7%14.2 $4.05 8/31/2022628,200 shares $2.67 million No Change20.9%12.2 $4.25 8/15/2022628,200 shares $3.46 million -1.8%19.5%11.5 $5.50 7/31/2022639,500 shares $3.75 million -1.1%21.3%10.5 $5.86 7/15/2022646,300 shares $3.71 million -3.5%21.5%9.4 $5.74 6/30/2022669,700 shares $3.32 million -23.6%25.5%9.3 $4.95 6/15/2022876,100 shares $5.26 million -0.3%33.3%12.3 $6.00 5/31/2022878,600 shares $5.47 million +3.2%35.0%15.7 $6.23 5/15/2022851,000 shares $5.23 million +7.8%33.9%14.6 $6.15 4/30/2022789,300 shares $6.35 million +6.4%35.7%13.7 $8.04 4/15/2022742,200 shares $6.31 million -0.3%33.6%12.6 $8.50 3/31/2022744,400 shares $6.11 million +4.9%36.1%12.6 $8.21 3/15/2022709,600 shares $5.34 million +9.6%34.5%11.2 $7.52 2/28/2022647,600 shares $5.05 million +1.2%27.4%10.1 $7.80 2/15/2022639,800 shares $5.40 million +3.1%27.2%9.8 $8.44 1/31/2022620,400 shares $5.00 million -3.2%8.1%8.6 $8.06 1/15/2022640,600 shares $6.64 million -10.8%8.4%9.7 $10.36 12/31/2021718,500 shares $7.24 million +0.9%9.8%11.5 $10.08 12/15/2021712,300 shares $6.35 million -4.5%9.7%13.5 $8.92 11/30/2021745,700 shares $7.46 million -0.7%10.2%12.6 $10.00 11/15/2021750,800 shares $9.63 million -6.2%10.2%13.3 $12.83 10/29/2021800,400 shares $12.13 million -7.6%10.9%15.2 $15.16 10/15/2021865,900 shares $13.57 million +1.3%11.8%17.3 $15.67 9/30/2021854,600 shares $13.55 million +27.3%12.7%16.2 $15.85 9/15/2021671,400 shares $11.78 million +6.5%10.0%9.4 $17.54 8/31/2021630,400 shares $13.39 million +4.2%9.4%7.6 $21.24 8/13/2021605,200 shares $12.44 million No Change9.0%7 $20.55Is President Trump Lying To You With This? (Ad)President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.Protect your IRA—Trump’s warning was real NPCE Short Interest - Frequently Asked Questions What is NeuroPace's current short interest? Short interest is the volume of NeuroPace shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 393,700 shares of NPCE short. 1.70% of NeuroPace's shares are currently sold short. Learn More on NeuroPace's current short interest. What is a good short interest ratio for NeuroPace? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NPCE shares currently have a short interest ratio of 2.0. Learn More on NeuroPace's short interest ratio. Which institutional investors are shorting NeuroPace? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NeuroPace: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for NeuroPace? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.70% of NeuroPace's floating shares are currently sold short. Is NeuroPace's short interest increasing or decreasing? NeuroPace saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 393,700 shares, an increase of 13.3% from the previous total of 347,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NeuroPace's float size? NeuroPace currently has issued a total of 32,799,000 shares. Some of NeuroPace's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroPace currently has a public float of 23,130,000 shares. How does NeuroPace's short interest compare to its competitors? 1.70% of NeuroPace's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to NeuroPace: Tandem Diabetes Care, Inc. (10.33%), Cadre Holdings, Inc. (7.50%), National Vision Holdings, Inc. (9.70%), Liquidia Co. (15.84%), Artivion, Inc. (9.07%), BioLife Solutions, Inc. (8.29%), Pulse Biosciences, Inc. (18.95%), Paragon 28, Inc. (2.22%), MiMedx Group, Inc. (3.24%), InMode Ltd. (9.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short NeuroPace stock? Short selling NPCE is an investing strategy that aims to generate trading profit from NeuroPace as its price is falling. NPCE shares are trading down $0.37 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroPace? A short squeeze for NeuroPace occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NPCE, which in turn drives the price of the stock up even further. How often is NeuroPace's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NPCE, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies TNDM Short Interest Data CDRE Short Interest Data EYE Short Interest Data LQDA Short Interest Data AORT Short Interest Data BLFS Short Interest Data PLSE Short Interest Data FNA Short Interest Data MDXG Short Interest Data INMD Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NPCE) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NPCE Stock Free NPCE Stock Alerts